** Shares of INOVIQ IIQ.AX rise as much as 23.9% to
A$0.700, set to gain most since June 3, if current gains hold
** The cancer therapy co says it has completed placement to
raise A$7 mln ($4.63 mln) to advance research of cancer
therapeutics, among others
** Co says funds will also be used for commercialisation of
SubB2M diagnostics - a pan-cancer detection technology
** Stock hits its highest level since June 3
** About 1.9 mln shares change hands, compared with the
30-day average volume of 230,189
** INOVIQ stock down 15% this year, as of last close
($1 = 1.5126 Australian dollars)
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com;))